Specify a stock or a cryptocurrency in the search bar to get a summary
Instil Bio Inc.
TILInstil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the treatment of cancer. It is developing early-stage pipeline of CoStAR-TIL and other novel TIL technologies. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas. Address: 3963 Maple Avenue, Dallas, TX, United States, 75219
Analytics
WallStreet Target Price
103.67 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures TIL
Dividend Analytics TIL
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History TIL
Stock Valuation TIL
Financials TIL
Results | 2019 | Dynamics |